with Anthony Rostain, M.D., MA
Treatment for ADHD women during the transition to menopause and beyond requires modifications that takes into account their changing neurobiology. Understanding these changes can facilitate better communication with health care providers and can help women develop better strategies for coping with daily life.
$13.00
Aging places increasing demands on adults with ADHD. Women in mid-life are especially challenged by the multiple role demands placed on them (career, family relationships, housework, etc). Menopause adds additional stresses especially when it affects executive functioning.
Treatment for ADHD women during the transition to menopause and beyond requires modifications that takes into account their changing neurobiology. Understanding these changes can facilitate better communication with health care providers and can help women develop better strategies for coping with daily life.
Anthony L. Rostain, M.D., is a psychiatrist in the Department of Child and Adolescent Psychiatry and Behavioral Sciences and the Center for Management of ADHD at CHOP, and director of the Developmental Neuropsychiatry Program. Areas of Expertise: Complex neurodevelopmental disorders across the lifespan, Integrating psychosocial and medical treatments for ADHD and related disorders, Managing the transition from adolescent to young adult treatment settings, ADHD, Medical student education, Neuropsychiatric disorders, Residency training.